A Study of Pridopidine (ACR16) for the Treatment of Participants With Huntington's Disease
Public ClinicalTrials.gov record NCT00724048. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, North American, Randomized, Double-blind, Parallel Group Study Comparing Three Doses of ACR16 Versus Placebo for the Symptomatic Treatment of Huntington Disease (HART)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine if ACR16 is effective and safe in the symptomatic treatment of Huntington's Disease.
Study identification
- NCT ID
- NCT00724048
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 227 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 30 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 23, 2008
- Primary completion
- Jul 25, 2010
- Completion
- Jul 25, 2010
- Last update posted
- Aug 30, 2023
2008 – 2010
United States locations
- U.S. sites
- 22
- U.S. states
- 17
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35233 | — |
| University of California | San Diego | California | 92161 | — |
| Colorado Neurological Institute | Littleton | Colorado | 80120 | — |
| University of South Florida | Tampa | Florida | 33612 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Indiana University School of Medicine | Indianapolis | Indiana | 46202 | — |
| University of Iowa | Iowa City | Iowa | 52242 | — |
| University of Maryland School of Medicine | Baltimore | Maryland | 21201 | — |
| Johns Hopkins University | Baltimore | Maryland | 21287-7281 | — |
| Massachusetts General Hospital | Charlestown | Massachusetts | 02129 | — |
| Struthers Parkinson's Center | Saint Louis Park | Minnesota | 55426 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Albany Medical College | Albany | New York | 12208 | — |
| North Shore-LIJ Health System | Manhasset | New York | 11030 | — |
| University of Rochester | Rochester | New York | 14618 | — |
| University of Cincinnati | Cincinnati | Ohio | 45219 | — |
| Ohio State University Parkinson's Center | Columbus | Ohio | 43210 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19107 | — |
| University of Tennessee Health Science Center | Memphis | Tennessee | 38163 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390-9036 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| Booth Gardner Parkinson's Care Center | Kirkland | Washington | 98034 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00724048, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 30, 2023 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00724048 live on ClinicalTrials.gov.